Aristotle Capital Boston LLC Has $10.17 Million Stock Position in Herbalife Ltd $HLF

Aristotle Capital Boston LLC lowered its position in shares of Herbalife Ltd (NYSE:HLF) by 9.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 788,588 shares of the company’s stock after selling 84,652 shares during the period. Aristotle Capital Boston LLC owned about 0.76% of Herbalife worth $10,165,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Boothbay Fund Management LLC grew its position in Herbalife by 414.5% during the 4th quarter. Boothbay Fund Management LLC now owns 64,187 shares of the company’s stock worth $827,000 after acquiring an additional 51,711 shares during the last quarter. Quantedge Capital Pte Ltd grew its position in Herbalife by 5.2% during the 4th quarter. Quantedge Capital Pte Ltd now owns 2,249,683 shares of the company’s stock worth $28,998,000 after acquiring an additional 111,700 shares during the last quarter. Public Employees Retirement System of Ohio grew its position in Herbalife by 144.2% during the 4th quarter. Public Employees Retirement System of Ohio now owns 37,127 shares of the company’s stock worth $479,000 after acquiring an additional 21,926 shares during the last quarter. Mangrove Partners IM LLC bought a new stake in Herbalife during the 4th quarter worth $175,000. Finally, Squarepoint Ops LLC bought a new stake in Herbalife during the 4th quarter worth $2,161,000.

Insider Transactions at Herbalife

In other Herbalife news, COO Troy Hicks sold 10,000 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $12.32, for a total value of $123,200.00. Following the sale, the chief operating officer owned 9,706 shares in the company, valued at approximately $119,577.92. The trade was a 50.75% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Frank Lamberti sold 134,982 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total value of $1,822,257.00. Following the sale, the insider owned 36,624 shares in the company, valued at approximately $494,424. The trade was a 78.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 191,296 shares of company stock worth $2,551,678 in the last quarter. Corporate insiders own 5.13% of the company’s stock.

Herbalife Trading Down 1.5%

NYSE HLF opened at $11.65 on Thursday. The business’s 50-day moving average price is $13.86 and its two-hundred day moving average price is $14.87. Herbalife Ltd has a 12 month low of $7.56 and a 12 month high of $20.40. The firm has a market capitalization of $1.21 billion, a PE ratio of 5.11, a price-to-earnings-growth ratio of 0.70 and a beta of 0.88.

Herbalife (NYSE:HLF) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.30 billion. During the same quarter in the previous year, the company posted $0.59 EPS. The business’s revenue was up 7.8% on a year-over-year basis. As a group, analysts forecast that Herbalife Ltd will post 2.47 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on HLF shares. Zacks Research lowered Herbalife from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Wall Street Zen upgraded Herbalife from a “buy” rating to a “strong-buy” rating in a research report on Saturday, April 18th. Mizuho set a $17.00 price objective on Herbalife in a research report on Monday, May 4th. Citigroup restated a “buy” rating and set a $21.00 price objective (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Finally, Weiss Ratings upgraded Herbalife from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday. Three investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.80.

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.